RecruitingPhase 2NCT07459647
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Sponsor: MapLight Therapeutics
Gaithersburg, MD · +44 more sites
Schizophrenia clinical trials in Gaithersburg, MD
13 recruiting schizophrenia studies with a site in Gaithersburg, MD.
RecruitingPhase 2NCT07410507
A Study of Brenipatide in Adult Participants With Schizophrenia
Sponsor: Eli Lilly and Company
Gaithersburg, MD · +31 more sites
RecruitingPhase 3NCT07686263
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Gaithersburg, MD · +33 more sites
RecruitingPhase 3NCT07114874
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Sponsor: Neurocrine Biosciences
Gaithersburg, MD · +49 more sites
RecruitingPhase 1NCT07734493
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Sponsor: Leal Therapeutics, Inc
Gaithersburg, MD · +9 more sites
RecruitingPhase 2NCT07145918
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Sponsor: AbbVie
Gaithersburg, MD · +6 more sites
RecruitingPhase 3NCT07369154
52-week Open Label Safety-Tolerability Study
Sponsor: LB Pharmaceuticals Inc.
Gaithersburg, MD · +22 more sites
RecruitingPhase 3NCT07565428
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
Sponsor: Minerva Neurosciences
Gaithersburg, MD · +12 more sites
RecruitingPhase 2NCT07191483
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Sponsor: Kynexis B.V.
Gaithersburg, MD · +14 more sites
RecruitingPhase 3NCT06963034
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Sponsor: Neurocrine Biosciences
Gaithersburg, MD · +20 more sites
RecruitingPhase 2NCT06502964
Study of ALTO-101 in Patients With Schizophrenia
Sponsor: Alto Neuroscience
Gaithersburg, MD · +13 more sites
RecruitingPhase 3NCT05184335
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Sponsor: Reviva Pharmaceuticals
Gaithersburg, MD · +17 more sites
Not yet recruitingPhase 4NCT06924255
An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia
Sponsor: Collaborative Neuroscience Research, LLC
Gaithersburg, MD · +6 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.